AZN
Price
$157.97
Change
+$1.44 (+0.92%)
Updated
Oct 6, 11:02 AM (EDT)
Capitalization
256.26B
24 days until earnings call
Intraday BUY SELL Signals
LLY
Price
$1159.20
Change
+$16.08 (+1.41%)
Updated
Oct 6, 11:06 AM (EDT)
Capitalization
1.06T
23 days until earnings call
Intraday BUY SELL Signals
MRK
Price
$141.05
Change
+$1.51 (+1.08%)
Updated
Oct 6, 11:07 AM (EDT)
Capitalization
366.84B
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZN or LLY or MRK

AZN vs LLY vs MRK Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
AZN vs LLY vs MRK: Fundamental Ratings
AZN
LLY
MRK
OUTLOOK RATING
1..100
742368
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
51
Fair valued
11
Undervalued
PROFIT vs RISK RATING
1..100
221235
SMR RATING
1..100
441479
PRICE GROWTH RATING
1..100
504440
P/E GROWTH RATING
1..100
52582
SEASONALITY SCORE
1..100
73050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZN's Valuation (7) in the Pharmaceuticals Major industry is in the same range as MRK (11) and is somewhat better than the same rating for LLY (51). This means that AZN's stock grew similarly to MRK’s and somewhat faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (12) in the Pharmaceuticals Major industry is in the same range as AZN (22) and is in the same range as MRK (35). This means that LLY's stock grew similarly to AZN’s and similarly to MRK’s over the last 12 months.

LLY's SMR Rating (14) in the Pharmaceuticals Major industry is in the same range as AZN (44) and is somewhat better than the same rating for MRK (79). This means that LLY's stock grew similarly to AZN’s and somewhat faster than MRK’s over the last 12 months.

MRK's Price Growth Rating (40) in the Pharmaceuticals Major industry is in the same range as LLY (44) and is in the same range as AZN (50). This means that MRK's stock grew similarly to LLY’s and similarly to AZN’s over the last 12 months.

MRK's P/E Growth Rating (2) in the Pharmaceuticals Major industry is somewhat better than the same rating for AZN (52) and is somewhat better than the same rating for LLY (58). This means that MRK's stock grew somewhat faster than AZN’s and somewhat faster than LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNLLYMRK
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
48%
MACD
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
42%
Advances
ODDS (%)
Bullish Trend 12 days ago
57%
Bullish Trend 9 days ago
70%
Bullish Trend 15 days ago
58%
Declines
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 5 days ago
55%
Bearish Trend 6 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
59%
N/A
Bullish Trend 1 day ago
60%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
64%
COMPARISON
Comparison
Oct 06, 2026
Stock price -- (AZN: $156.53, LLY: $1143.12, MRK: $139.54)
Brand notoriety: AZN, LLY and MRK are all notable
The three companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 56%, LLY: 78%, MRK: 94%
Market capitalization -- AZN: $256.26B, LLY: $1.06T, MRK: $366.84B
$AZN is valued at $256.26B, while LLY has a market capitalization of $1.06T, and MRK's market capitalization is $366.84B. The market cap for tickers in this @Pharmaceuticals: Major ranges from $4.8K to $1.06T. The average market capitalization across the @Pharmaceuticals: Major industry is $200.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 2 FA rating(s) are green while LLY’s FA Score has 2 green FA rating(s), and MRK’s FA Score reflects 2 green FA rating(s).

  • AZN’s FA Score: 2 green, 3 red.
  • LLY’s FA Score: 2 green, 3 red.
  • MRK’s FA Score: 2 green, 3 red.
According to our system of comparison, AZN is a better buy in the long-term than MRK, which in turn is a better option than LLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 3 TA indicator(s) are bullish while LLY’s TA Score has 3 bullish TA indicator(s), and MRK’s TA Score reflects 4 bullish TA indicator(s).

  • AZN’s TA Score: 3 bullish, 6 bearish.
  • LLY’s TA Score: 3 bullish, 6 bearish.
  • MRK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MRK is a better buy in the short-term than AZN, which in turn is a better option than LLY.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а -5.79% price change this week, while LLY (@Pharmaceuticals: Major) price change was -3.52% , and MRK (@Pharmaceuticals: Major) price fluctuated -6.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.19%. For the same industry, the average monthly price growth was -6.62%, and the average quarterly price growth was +8.13%.

Reported Earning Dates

AZN is expected to report earnings on Oct 30, 2026.

LLY is expected to report earnings on Oct 29, 2026.

MRK is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-4.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
AZN
Daily Signal:
Gain/Loss:
LLY
Daily Signal:
Gain/Loss:
MRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRQR1.670.03
+2.14%
ProQR Therapeutics NV
PSA281.66-2.15
-0.76%
Public Storage
TLF2.49-0.02
-0.80%
Tandy Leather Factory
EBC21.24-0.23
-1.05%
Eastern Bankshares
TE3.70-0.22
-5.61%
T1 Energy Inc.

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with BIIB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-0.24%
BIIB - AZN
48%
Loosely correlated
+1.69%
LLY - AZN
44%
Loosely correlated
+0.02%
GILD - AZN
39%
Loosely correlated
-0.08%
MRK - AZN
28%
Poorly correlated
-3.30%
GSK - AZN
27%
Poorly correlated
-1.02%
More

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with JNJ. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+0.02%
JNJ - LLY
45%
Loosely correlated
-1.21%
PFE - LLY
45%
Loosely correlated
-1.40%
AMGN - LLY
44%
Loosely correlated
-0.01%
MRK - LLY
44%
Loosely correlated
-3.30%
BMY - LLY
42%
Loosely correlated
-3.83%
More

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with GSK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-3.30%
GSK - MRK
53%
Loosely correlated
-1.02%
PFE - MRK
50%
Loosely correlated
-1.40%
NVS - MRK
49%
Loosely correlated
-0.05%
JNJ - MRK
48%
Loosely correlated
-1.21%
BMY - MRK
47%
Loosely correlated
-3.83%
More